SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Roth Capital Initiates Coverage On GlycoMimetics with Buy Rating, Announces $12 Price Target

Roth Capital initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Buy rating and a $12 price target.

Benzinga · -

Roth Capital initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Buy rating and a $12 price target.